1 learning resource available for this topic
Rhabdomyolysis is a potentially life-threatening condition characterized by the breakdown of skeletal muscle tissue, leading to the release of intracellular contents into the bloodstream. This muscle destruction can result from various causes including trauma, drug toxicity, infections, or metabolic disorders, and may progress to acute kidney injury if untreated.
Muscle cell damage leads to disruption of the sarcolemma and release of intracellular components including myoglobin, creatine kinase, potassium, and phosphate into the circulation. Myoglobin is filtered by the kidneys but can precipitate in acidic urine, causing tubular obstruction and direct nephrotoxicity, while the massive cellular release can lead to hyperkalemia, hyperphosphatemia, and hypocalcemia.
Diagnosis is suspected in patients presenting with muscle pain, weakness, and dark urine, particularly following known triggers such as crush injuries, prolonged immobilization, or statin use. Laboratory confirmation shows markedly elevated creatine kinase levels (typically >5x normal), elevated myoglobin, and potential electrolyte abnormalities, with early aggressive fluid resuscitation being crucial to prevent acute kidney injury and manage electrolyte imbalances.